Medical Abortion Clinical Trial
Official title:
The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks: A Prospective Cohort Study in Mexico City
The purpose of this study is to assess the effectiveness, safety, and acceptability of home-administered medical abortion at gestational age of 8 to ≤9 weeks versus >9 to ≤12 weeks among a cohort of women in Mexico City.
Medical abortion represents an important alternative to surgical methods for termination of early pregnancy. In Mexico City, abortion is legal on request up to 12 weeks of gestation; however, medical abortion is currently only offered up to 10 weeks at Marie Stopes Mexico clinics. The World Health Organization guidelines state that medical abortion drugs may be used to terminate pregnancy up to a gestational age of 24 weeks in clinical settings, with recommended regimens differing by gestational age. However, data are lacking on the safety and effectiveness of home-based medical abortion regimens for pregnancy terminations between >9 and ≤12 weeks' gestation. Investigators propose a prospective cohort study with women between 8 and ≤9 weeks and >9 and ≤12 weeks of pregnancy at Marie Stopes Mexico clinics to compare the effectiveness, safety, and acceptability of mifepristone followed by home-based misoprostol use in these two gestational age groups. The information from this study will inform policy and practice guidelines in Mexico City and potentially other locations by providing evidence on the safety, effectiveness, and acceptability of home-use of medical abortion between >9 and ≤12 weeks of gestation. ;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02570204 -
Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests
|
N/A | |
| Completed |
NCT01487213 -
Routine Follow-up Versus Self-assessment in Medical Abortion
|
N/A | |
| Terminated |
NCT05119439 -
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
|
Phase 4 | |
| Terminated |
NCT04941443 -
Methadone and Medication Abortion
|
Phase 4 | |
| Completed |
NCT02985229 -
Acceptability and Feasibility of Medical Abortion in Singapore
|
Phase 3 | |
| Completed |
NCT01920022 -
Quickstart of Nexplanon® at Medical Abortion
|
Phase 4 | |
| Completed |
NCT00472394 -
Determining Women's Preferences for Medical Abortion Using Willingness to Pay
|
N/A | |
| Completed |
NCT03604341 -
Cannabinoids for Pain Control During Medical Abortion
|
Phase 4 | |
| Completed |
NCT00907725 -
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
|
N/A | |
| Completed |
NCT00120224 -
De-Medicalizing Mifepristone Medical Abortion
|
N/A | |
| Completed |
NCT03148587 -
Medical Abortion Self-Confirmation (MASC)
|
N/A | |
| Completed |
NCT00621543 -
Insertion of an Intrauterine Device (IUD) After Medical Abortion
|
N/A | |
| Completed |
NCT02343913 -
Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan
|
N/A | |
| Completed |
NCT01856777 -
Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy
|
N/A | |
| Recruiting |
NCT00920465 -
Treatment Regimens for Mifegyne and Cytotec
|
Phase 3 | |
| Completed |
NCT05532085 -
Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
|
||
| Completed |
NCT00997347 -
The Extended Gestational Age Medical Abortion Study
|
Phase 4 | |
| Completed |
NCT03014193 -
Simplifying First Trimester Medical Abortion Follow-up
|
N/A | |
| Recruiting |
NCT04905251 -
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
|
||
| Completed |
NCT04181541 -
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
|
N/A |